Empowered Funds’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding LCTX
Empowered Funds's LCTX Position: Q3 2026 in Review
Empowered Funds opened a new position in Lineage Cell Therapeutics (LCTX) in Q3 2026: 217,326 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #2227 among its holdings.
143 funds tracked by Wall St. Rank hold LCTX as of Q3 2026.
- Empowered Funds held 217,326 shares of Lineage Cell Therapeutics worth $208K as of Q3 2026.
- Lineage Cell Therapeutics was a new Empowered Funds position in Q3 2026.
- Lineage Cell Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2227 holding.
- 143 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q3 2026.
Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.